HIV protease inhibitors and Pneumocystis

Journal of Eukaryotic Microbiology

Volumn 51, Issue 3, 2004, Pages 376-377

  Fantoni, Giovanna ^a   Atzori, Chiara ^a   Tronconi, Elisa ^a   Valerio, Antonella ^a   Tartarone, Federica ^a   Cargnel, Antonietta ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS;

EID: 2542421947     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2004.tb00583.x     Document Type: Article

References (13)

1. Andre, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth, B. L. Jr, Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M. & Lotteau, V. 1998. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA, 95:13120-13124.
2. Atzori, C., Mainini, A., Agostoni, F., Angeli, E., Bartlett, M., Bruno, A., Scaglia, M. & Cargnel, A. 1999. Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase ihibitors in vitro. Parasite, 6:9-16.
3. Atzori, C., Angeli, E., Mainini, A., Agostoni, F., Micheli, V. & Cargnel, A. 2000. In vitro activity of human immunodeficiency virus protease inihibitors against Pneumocystis carinii. J. Infect. Dis., 181: 1629-1634.
4. Atzori, C., Fantoni, G., Valerio, A. & Cargnel, A. 2001. In vitro activity of amprenavir against Pneumocystis carinii. Int. J. Antimicrob Agents, 18:271-273.
5. Atzori, C., Clerici, M., Trabattoni, D., Fantoni, G., Valerio, A., Tronconi, E. & Cargnel, A. 2003. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens. J. Antimicrob. Chemother., (Epub ahead of print).
6. Atzori, C., Villani, P., Regazzi, M., Maruzzi, M. & Cargnel, A. 2003. Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient. AIDS, 17:1710-1711.
7. Cassone, A., De Bernardis, F., Torosantucci, A., Tacconelli, E., Tumbarello, M. & Cauda, R. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. Infect. Dis., 180:448-453
8. Derouin, F. & Santillana-Hayat, M. 2002. Anti-Toxoplasma activity of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro. Antimicrobial. Agents Chemother., 44:2575-2577.
9. Lugli, E. B., Bampton, E. T., Ferguson, D. J. & Wakefield, A. E. 1999. Cell surface protease PRT1 identified in the fungal pathogen Pneumocystis carinii. Mol. Microbiol., 31:1723-1733.
10. Morris, A., Wachter, R. M., Luce, J., Turner, J. & Huang, L. 2003. Improved survival with highly active antiretroviral therapy in HIV infected patients with severe Pneumocystis carinii pneumonia. AIDS, 17:73-80.
11. Sepkowitz, K. A. 1998. Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet, 351:228-230.
12. Wada, M. & Nakamura, Y. 1991. Immunological characterization of surface subtilisin-like protease (SSP) of Pneumocystis carinii. J. Eukaryot. Microbiol., 46:1515-1525.
13. Walzer, P. D., Ashbaugh, A., Collins, M. & Cushion, M. T. 2001. Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo. J. Infect. Dis., 184:1355-1357.